Case report on dermatitis secondary to hypersensitivity to icodextrin, which is a rare complication of icodextrin therapy in peritoneal dialysis.
CLINICAL PRESENTATION
A 56-year-old Chinese man has a 26-year history of Type II diabetes mellitus complicated by retinopathy and nephropathy. He developed endstage renal disease in March 2006. His past medical history includes hypertension, ischaemic heart disease and hyperlipidaemia. He was started on continuous ambulatory peritoneal dialysis (CAPD) with 3 x 1.6 L 1.5% glucose and 1 x 1.6L 2.5% glucose daytime exchanges. There was no overnight dwell as he still had significant residual renal function.
At his routine one-month review after the initiation of peritoneal dialysis, his peritoneal equilibrium test showed that he is a low average transporter. Kt/V was satisfactory at 1.97, and daily urine volume was 1200mL. He had no issues on peritoneal dialysis but was noted to have HbA1c 9.4%. He was also oedematous, despite achieving daily ultrafiltration volumes of 800mL. He was advised to restrict fluid intake and his insulin was increased.
He was then reviewed three months later. He still had poor glycaemic control despite the increase in insulin therapy, and remained oedematous.
Daily ultrafiltration volumes remained unchanged at 800mL per day on average. Fluid restriction was emphasised. He was started on icodextrin exchange overnight as a glucose sparing agent, and also to increase fluid removal.
Three weeks after starting icodextrin, the patient complained of pruritus. There was no obvious rash at this time.
The subsequent week, he was reviewed in clinic. He was less oedematous, and had lost 2kg. He achieved ultrafiltration volumes of up to 1700mL with the icodextrin. However, he had a florid dermatitis over his hands, feet and trunk ( Figs. 1 and 2) .
DIAGNOSIS
Dermatitis secondary to hypersensitivity with icodextrin.
TREATMENT
The patient was advised to stop the icodextrin exchange and replace it with his usual hypertonic glucose dialysate (2.5%). One month later, the rash was markedly improved. Subsequently, the patient Imaging Proceedings of Singapore Healthcare  Volume 21  Number 2  2012 continued to have persistent hyperglycaemia, hypertension and oedema despite medical therapy and he was converted to haemodialysis after 18 months on CAPD.
DISCUSSION
Icodextrin can offer superior ultrafiltration, especially in diabetic CAPD patients 1 . However, rash and dermatitis are rare complications of icodextrin therapy, and can be severe 2 . 
